Ad & Dementia Pathogenesis

Alzheimer's Disease (AD) and dementia are complex neurodegenerative disorders characterized by progressive cognitive decline. AD, the most common form of dementia, is associated with the accumulation of beta-amyloid plaques and tau protein tangles in the brain, leading to neuronal damage and cell death. These pathological changes disrupt communication between brain cells, particularly in areas responsible for memory, learning, and decision-making.

The pathogenesis involves a cascade of events: initial subtle memory impairments progressing to profound cognitive deficits and functional impairment. Genetic factors (such as mutations in APP, PSEN1, PSEN2 genes) and environmental influences contribute to disease onset. Neuroinflammation and oxidative stress further exacerbate neuronal damage. Diagnosis typically involves clinical evaluation, imaging (e.g., MRI, PET scans), and sometimes cerebrospinal fluid analysis. Management focuses on symptom relief through medications (e.g., cholinesterase inhibitors, memantine) and supportive care. Research continues into understanding underlying mechanisms and developing therapies to modify disease progression.